To seek long term capital growth principally through investment in UK Companies.
Name | % Net Assets |
---|---|
CAPE PLC | 8.9% |
HUTCHISON CHINA MEDITECH | 7.8% |
ANDOR TECHNOLOGY | 5.7% |
BRITISH AMERICAN TOBACCO | 4.8% |
GLAXOSMITHKLINE | 4.4% |
DIALIGHT | 4.3% |
ADVANCED MEDICAL SOLUTIONS GROUP | 4.3% |
CITY OF LONDON INVESTMENT GROUP | 4.1% |
IMPERIAL TOBACCO GROUP | 3.8% |
AVANTI COMMUNICATIONS GROUP PLC | 3.8% |
Key | % Net Assets |
---|---|
CAPE PLC | 8.9% |
HUTCHISON CHINA MEDITECH | 7.8% |
ANDOR TECHNOLOGY | 5.7% |
BRITISH AMERICAN TOBACCO | 4.8% |
Other | 72.8% |
Date | 21-Nov-2024 |
---|---|
NAV | 146.41p |
Currency | GBP |
Change | -2.31p |
% | -0.38% |
YTD change | -2.53p |
YTD % | -0.41% |
Fund Inception | 30/03/2005 |
---|---|
Fund Manager | n/a |
TER | 1.52 (31-Dec-2011) |
Minimum Investment | |
---|---|
Initial | £3000 |
Additional | £1,000 |
Savings | n/a |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.13 |
You are here: research